Search clinical trials for: immunological markers

Total 16140 results

Jing-yuan Fang, MD, Ph. D

Recruiting

Tislelizumab With Fruquintinib, Metronidazole, in Mismatch Repair-proficient or Microsatellite Stability, Advanced Colorectal Cancer: a Multicenter, Single Arm, Clinical Trial

Colorectal Cancer

China
The Republican Research and Practical Center for...
Belarusian State Medical University

Recruiting

To Develop an Algorithm for Predicting the Unfavorable Course of Sepsis in Children Based on a Comprehensive Assessment of Immunological, Biochemical and Molecular Genetic Markers

Sepsis

Belarus
Vastra Gotaland Region

Recruiting

Validating Immunological Markers Associated With Mental Fatigue in Graves' Disease

Mental Fatigue | Graves Disease

Sweden
Nazarbayev University
Ministry of Education and Science, Republic of Kazakhstan

Not yet recruiting

Immunological Profile and Microbial Markers in Evaluating the Effectiveness of Probiotic Therapy in RA Patients

Rheumatoid Arthritis
Vastra Gotaland Region

Recruiting

Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease

Autoimmune Diseases | Thyroid Diseases | Mental Fatigue | Graves Ophthalmopathy | Graves Disease

Sweden
ART Fertility Clinics LLC

Recruiting

Descriptive Analysis of Serum Immunological Markers During an Euploid Frozen Embryo Transfer in a Natural Cycle.

Infertility, Female

United Arab Emirates
Centre Leon Berard

Recruiting

A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments (ATEZOGIST)

Metastatic Gastrointestinal Stromal Tumor | Unresectable Gastrointestinal Stromal Tumor (GIST) | Locally Advanced Gastrointestinal Stromal Tumor (GIST)

France
University Hospital, Bonn

Recruiting

Immunophenotyping in Patients With Osteoporosis (IPO)

Immunophenotyping Blood Samples of Patients With Osteoporosis

Germany
University Hospital, Brest

Recruiting

Immunological Markers Predictive of Response and Toxicity to Checkpoint Inhibitors in Non-small Cell Lung Cancer (IMMUNO-PREDICT)

Lung Cancer

France
Oncodesign SA

Recruiting

OncoSNIPE - Study of Molecular Profiles Associated With the Development of Resistance in Solid Cancer Patients (OncoSNIPE)

CANCER

France
National University Health System, Singapore

Recruiting

Lymphocyte Markers As Predictors Of Responsiveness To Rituximab Among Patients With Idiopathic Nephrotic Syndrome

Nephrotic Syndrome

Singapore
Grupo Espanol de Investigacion en Sarcomas

Recruiting

Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas (ImmunoSarc)

Soft Tissue Sarcoma | Bone Sarcoma

Spain, United Kingdom, Italy
Sandra Lord, MD
Juvenile Diabetes Research Foundation; Medical College of Wisconsin

Completed

Early Markers of Disease and Response to Therapy

Type 1 Diabetes

United States
Foundation IRCCS San Matteo Hospital

Active, not recruiting

HPV Immunological Markers of Cervical Persistent Infection and Oncogenesis (HPVImmuno)

HPV-Related Cervical Carcinoma

Italy
Milton S. Hershey Medical Center

Withdrawn

Effect of Protocatechuic Acid on Biochemical Markers of Immunity Status in Healthy Adults

Immunity

United States
Universiteit Antwerpen
UZA Foundation

Active, not recruiting

Neurobiological Underpinnings of Neuropsychological Consequences in Long COVID (Cov-N-Psy)

Long COVID

Belgium
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer

Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | HER2 Positive Breast Carcinoma

United States
Advaxis, Inc.
MedImmune LLC

Terminated

A Study of ADXS11-001 or MEDI4736 Alone or Combination In Cervical or Human Papillomavirus (HPV)+ Head & Neck Cancer

Cervical Cancer | Cancer | Head and Neck Cancer

United States
Northumbria University

Completed

The Effects of a Multi-ingredient Night-time Tea on Sleep Quality, Wellbeing and Markers of Immune Function

Sleep | Mood | Poor Quality Sleep | Good Sleep Habit

United Kingdom
Aarhus University Hospital

Completed

Co-stimulatory Markers and Vitamin D Status in Anti-PD1 Treated Melanoma Patients

Malignant Melanoma

Denmark
Technological Centre of Nutrition and Health, Spain
Hospital Universitari Sant Joan de Reus; Biopolis S.L.; Technological Centre...

Completed

The Dysbiosis of the Intestinal Microbiota in Individuals With Allergic Rhinitis (MICRORIN) (MICRORIN)

Allergic Rhinitis

Spain
National Cancer Institute (NCI)

Completed

EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated Lymphoma

AIDS Related Lymphoma | AIDS-Associated Lymphoma

United States
OmicsWay Corp.
Oncobox Ltd., Russia; Vitamed LLC, Russia; Republican Oncological Dispensary...

Active, not recruiting

Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer

HER2-positive Breast Cancer

United States, Russian Federation
Pfizer
Merck Sharp & Dohme LLC

Completed

A Dose Finding Study To Evaluate Safety, Drug Interaction, Tumor Markers Of Axitinib In Combination With MK-3475 In Adult Patients With Previously Untreated Advanced Renal Cell Cancer

Renal Cell Carcinoma

United States
Rocky Mountain MS Research Group, LLC
Biogen

Completed

Longitudinal Analysis And Sample Collection To Evaluate PML Risk Host Markers for PML Risk Host Markers for PML Risk (SRA-001)

Multiple Sclerosis

United States
Mansoura University

Completed

Can We Predict of the Response of High Risk Non Muscle Invasive Bladder Cancer Patients to Intravesical Bacillus Calmette-Guerin? The Role of Immunological Markers

Bladder Cancer

Egypt
University Hospital Muenster

Unknown

Signatures of Immune Reprogramming in Anti-CD52 Therapy of MS: Markers for Risk Stratification and Treatment Response (ProgramMS)

Multiple Sclerosis

Germany
West German Study Group
GlaxoSmithKline

Terminated

Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer

Carcinoma, Ductal, Breast

Germany
University Hospital, Bordeaux

Completed

Immunological Markers in Adult Patients With Immune Thrombocytopenic Purpura (SPLENOTIR)

Immune Thrombocytopenic Purpura | Splenectomy; Status
University of Chicago
Genzyme, a Sanofi Company

Completed

Alemtuzumab on Surrogate Markers of Disease Activity and Repair Using Advanced MRI Measures in Subjects With Relapsing Remitting Multiple Sclerosis

Multiple Sclerosis
Grupo Espanol Multidisciplinario del Cancer Digestivo
Amgen; TFS Trial Form Support

Completed

Study Assessing Potential Predictive Tumor Markers in Metastatic Colorectal Cancer (PULSE)

Metastatic Colorectal Cancer

Spain
National Cancer Institute (NCI)

Completed

Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer

Prostatic Neoplasms

United States
Bristol-Myers Squibb

Completed

Phase II Study to Determine Predictive Markers of Response to BMS-734016 (MDX-010)

Unresectable Stage III or IV Malignant Melanoma

United States, Peru, Norway, Italy, Sweden, Denmark, Israel
Thomas Hatschek

Unknown

A Translational Trial on Molecular Markers and Functional Imaging to Predict Response of Preoperative Treatment of Breast Cancer Early (PROMIX)

Breast Cancer

Sweden
Ain Shams University

Completed

The Effect of LMWH on ICSI in Patients With Unexplained Infertility and Negative Immunological Markers

Unexplained Infertility
Hospices Civils de Lyon

Completed

Evaluation of Immunological Markers, Inflammatory and Clinical Relapse Psychological Predictive During Crohn's Disease

Crohn Disease

France
University of California, San Francisco
Genentech, Inc.

Completed

Cardiovascular Risk Markers in Patients With Rheumatoid Arthritis: Effect of Rituximab Therapy

Inflammation | Rheumatoid Arthritis | Endothelial Function

United States
State Key Laboratory of Cancer Biology
Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Chinese... and other collaborators

Unknown

Immunological Markers Screening for Colorectal Cancer

Colorectal Cancer

China
National Taiwan University Hospital

Unknown

The Role of Inflammasome in Inflammatory Macrophage in Mycobacterium Avium Complex-lung Disease and Mycobacterium Abscessus-lung Disease

To Investigate the Inflammasome Response of Inflammatory and Resting Macrophage | To Compare the Difference of Inflammasome Response of Inflammatory Macrophage | To Study the Diagnostic Aid From Immunological Markers in Inflammasome Response

Taiwan
Clinica Universidad de Navarra, Universidad de...
Roche Farma, S.A

Completed

Study to Evaluate Markers of Response in Locally Advanced Breast Cancer (IMAGING)

Breast Neoplasms

Spain
Hadassah Medical Organization

Unknown

Effect of Partial Sleep Deprivation on Immunological System in Peripheral Blood

Sleep Deprivation

Israel
Centre Hospitalier Universitaire de Saint Etienne

Completed

Serologic Markers for Inflammatory Bowel Disease During Clinical Forms With Weak or Strong Evolution Capacities

Inflammatory Bowel Diseases

France
University Hospital, Strasbourg, France

Unknown

Study of the Role of Dendritic Cells in the Recurrence of Hepatitis C After Liver Transplantation. Analysis of Hepatitis C Virus (HCV) Quasispecies Evolution.

HCV Infection

France
University of KwaZulu
Bristol-Myers Squibb

Completed

Prophylactic Intrapartum Antibiotics and Immunological Markers for Postpartum Morbidity in HIV Positive Women

Puerperal Sepsis

South Africa
Zhongda Hospital

Recruiting

Efficacy and Safety of 90Y Microsphere Combined With FOLFIRI and Bevacizumab in Second-line Treatment of CRLM

Colorectal Cancer Metastatic

China
Pfizer

Recruiting

A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination (LTbR)

Melanoma | Colorectal Cancer | Non-Small Cell Lung Cancer | Urothelial Cancer | Advanced or Metastatic Solid Tumors

United States, Puerto Rico
M.D. Anderson Cancer Center
Kura Oncology, Inc.

Not yet recruiting

A Phase I Study Investigating the Combination of the Menin Inhibitor Ziftomenib With Venetoclax and Gemtuzumab in Pediatric Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic Leukemia

Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia

United States
Pfizer

Not yet recruiting

A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

Carcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Carcinoma, Pancreatic Ductal
M.D. Anderson Cancer Center
Regeneron Pharmaceuticals

Not yet recruiting

A Phase 2 Study to Evaluate the Efficacy of the Combination of Cemiplimab and Cetuximab Prior to Salvage Surgery in Patients With Locally Recurrent (Stage 3-5) OCSCC

Locally Recurrent OCSCC

United States

3

Subscribe